Résultats de recherche
27 août 2024 · PolyPeptide is a global CDMO for peptide-based active pharmaceutical ingredients, offering custom peptide synthesis and generic peptide products. Learn about its news, events, and video on its website.
- Services
PolyPeptide GMP services will tailor it production capacity...
- Generic peptides
Our GMP manufacturing facilities operate on stringent...
- Commercial Manufacturing
Commercial manufacturing is the ultimate goal to reach with...
- Custom R&D
The PolyPeptide product line includes manufacturing of...
- Cosmetic
Peptides have various cosmetic benefits and each peptide...
- Individualized Peptides
Individualized Peptide Therapeutics . In 2008, researchers...
- Oligos
Oligonucleotides. OLIGO@POLYPEPTIDE . We aim to become the...
- Investors
PolyPeptide Group AG with its consolidated subsidiaries...
- Services
POLYPEPTIDE LABORATORIES FRANCE, société par actions simplifiée, immatriculée sous le SIREN 414477695, est active depuis 26 ans. Implantée à STRASBOURG (67100), elle est spécialisée dans le secteur d'activité de la fabrication d'autres produits chimiques organiques de base.
- POLYPEPTIDE LABORATORIES FRANCE
PolyPeptide Laboratories France est la filiale française du groupe international PolyPeptide qui développe sous contrat CDMO (Contract Development and Manufacturing Organization) des ingrédients pharmaceutiques actifs (API) à base de peptides et d’oligonucléotides.
Polypeptide is a global company that develops and manufactures active ingredients for peptide- and oligonucleotide-based drugs. It serves pharma and biotech customers with over 70 years of experience and a focus on quality and innovation.
17 oct. 2024 · Opérations industrielles et commerciales dans le domaine des peptides de synthèse et des biotechnologies, brevet, test, stockage de produits finis. Code NAF ou APE : 20.14Z (Fabrication d'autres produits chimiques organiques de base) Domaine d’activité : Industrie chimique.
The Strasbourg, France site is a 65,000 square foot (~6,500 sq. meters) facility of which 35,000 square feet (~3,500 sq. meters) is dedicated for GMP manufacturing. The facility supports 7 independent synthesis units with solid phase reactors up to 200L and solution phase up to 650L in capacity.
Identifiez-vous pour voir qui vous connaissez déjà chez POLYPEPTIDE LABORATORIES FRANCE.
Peptide projects across the product life cycle, ISO and GMP, research to commerical phase. Biosynth's custom peptides support customers across research, development and beyond.